Clayton, Dubilier & Rice has added Dr. Manfred Schneider, former Chairman of the Supervisory Board of Bayer AG, as a new CD&R advisor. “We are delighted to welcome Manfred to the firm,” said Donald Gogel, Chairman and Chief Executive Officer of CD&R. “He is an exceptional global industrial leader with a track record of driving growth and innovation across three continents.”
In a career that has spanned over 45 years at Bayer, Dr. Schneider held a number of positions including Chairman of the Board of Management and Chairman of the Supervisory Board. Dr. Schneider is also on the Supervisory Boards of Linde AG, an industrial engineering company and RWE AG, a utility company.
During his decade-long tenure as Management Board Chairman, Dr. Schneider succeeded in expanding Bayer’s global market position consistently for ten years, achieving record financial results. During this period, Bayer’s market capitalization grew by about 200 percent. While CEO, Dr. Schneider focused on expanding Bayer’s research and development activities. He was also responsible for international expansion and bolstering the company’s positions in North American and Asian markets.
“CD&R’s approach combining investment judgment and operational expertise is very compelling to me and has particular relevance to European companies seeking to respond to an uncertain and challenging economic environment,” said Dr. Schneider. “I look forward to working with a firm that is one of the true pioneers of the industry.”
Clayton, Dubilier & Rice focuses on producing financial returns through building stronger more profitable businesses. Since inception, the firm has managed the investment of more than $18 billion in 52 businesses representing a range of industries with an aggregate transaction value of approximately $80 billion. Founded in 1978, Clayton, Dubilier & Rice is based in New York, NY and London, UK (www.cdr-inc.com).
© 2012 PEPD • Private Equity’s Leading News Magazine • 10-2-12
